Cue Biopharma CUE
NASDAQ CUE
$18.29 -0.60 (-3.18%)
As of: Oct 23, 2026 · 1:41 PM EDT

Cue Biopharma (CUE) Return on Sales [ROS] (2018 - 2026)

Updated

Cue Biopharma's Return on Sales [ROS] came in at -1113.30% for Q2 2026, down 820.99 percentage points from -292.32% a year earlier.

Analysis

Cue Biopharma (CUE) Return on Sales [ROS] (2018 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Cue Biopharma reported Return on Sales [ROS] of -291.93%, up 183.30 percentage points year-over-year; for FY2025, it came in at -96.67%, up 350.19 percentage points from FY2024.

  • Return on Sales [ROS] has increased in each of the last three years, with a five-year change of +1331.29 percentage points (FY2020 to FY2025).
  • Going back by year, Return on Sales [ROS] was -446.86% in FY2024 (+503.03 pp), -949.89% in FY2023 (+3325.21 pp), -4275.10% in FY2022 (-3982.54 pp) and -292.56% in FY2021 (+1135.41 pp).
  • The Q2 2026 figure represents the lowest quarterly Return on Sales [ROS] since Q1 2025.
  • Year-over-year, Return on Sales [ROS] increased in four of the last seven quarters, with an average year-over-year change of -278.19 percentage points.
  • The fastest year-over-year change in Return on Sales [ROS] over five years came in Q2 2023 (a gain of 49368.08 percentage points), and the weakest in Q2 2022 (a drop of 49969.99 percentage points).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,133.17 Bn 1,101.76 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 634.79 Bn 554.65 Bn 17.30 Bn 24.35%
3 AbbVie 506.40 Bn 479.51 Bn 12.70 Bn 37.86%
4 Merck 357.93 Bn 312.31 Bn 12.21 Bn -3.52%
5 Novartis Ag 292.69 Bn 256.68 Bn 11.24 Bn 32.97%
6 Astrazeneca 265.19 Bn 238.87 Bn 12.86 Bn 20.57%
7 Amgen 238.22 Bn 193.61 Bn 7.24 Bn 34.95%
8 Gilead Sciences 195.23 Bn 169.43 Bn 6.22 Bn -133.21%
9 Pfizer 171.11 Bn 117.76 Bn 10.94 Bn 28.37%
10 Cue Biopharma 116.04 Mn 25.31 Mn - -1,113.30%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1,113.30%
Dec 31, 2025 9.01%
Sep 30, 2025 -353.42%
Jun 30, 2025 -292.32%
Mar 31, 2025 -2,921.38%
Dec 31, 2024 -611.23%
Sep 30, 2024 -264.24%
Jun 30, 2024 -390.63%
Mar 31, 2024 -737.80%
Dec 31, 2023 -759.58%
Sep 30, 2023 -543.76%
Jun 30, 2023 -978.08%
Mar 31, 2023 -7,155.08%
Dec 31, 2022 -9,845.03%
Sep 30, 2022 -16,222.06%
Jun 30, 2022 -50,346.15%
Mar 31, 2022 -1,423.80%
Dec 31, 2021 -95.62%
Sep 30, 2021 -543.55%
Jun 30, 2021 -376.16%
API Access

Cue Biopharma Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=CUE&period=max&api_key=YOUR_API_KEY